[HTML][HTML] Management of Dyslipidaemia in Real-world Clinical Practice: Rationale and Design of the VIPFARMA ISCP Project
RL Santi, F Martinez, A Baranchuk… - European Cardiology …, 2021 - ncbi.nlm.nih.gov
Dyslipidaemia plays a major role in the pathogenesis of atherosclerosis. Every year,
scientific institutions publish cardiovascular prevention guidelines with updated goals and …
scientific institutions publish cardiovascular prevention guidelines with updated goals and …
Cost-effectiveness of rivaroxaban plus aspirin (dual pathway inhibition) for prevention of ischaemic events in patients with cardiovascular disease: on top optimisation …
B Rauch - European Journal of Preventive Cardiology, 2020 - journals.sagepub.com
In an attempt to optimise long-term prevention against adverse events in patients with
cardiovascular disease (CVD) several antithrombotic regimens have been tested as …
cardiovascular disease (CVD) several antithrombotic regimens have been tested as …
Взаємозв'язок ферокінетичних показників зі станом кардіального ремоделювання у хворих на ішемічну хворобу серця із супутнім залізодефіцитом
МО Коновалова, НС Михайловська - 2023 - dspace.zsmu.edu.ua
Мета роботи–оцінити взаємозв'язок ферокінетичних показників зі станом кардіального
ремоделювання у хворих на ішемічну хворобу серця (ІХС) залежно від ступеня …
ремоделювання у хворих на ішемічну хворобу серця (ІХС) залежно від ступеня …
Statins in the primary prevention of cardiovascular disease. Rosuvastatin capabilities
MG Bubnova, MY Ilchenko… - …, 2021 - cardiosomatics.orscience.ru
The article discusses the modern principles of lipid-lowering therapy and approaches to its
administration in terms of levels of cardiovascular risk. The characteristics of groups of …
administration in terms of levels of cardiovascular risk. The characteristics of groups of …
Triglyceride level as a potential marker of residual cardiovascular risk and its relation to HeartScore
E Ademović, M Čakarić… - … and Health Care, 2023 - content.iospress.com
23 BACKGROUND: Atherosclerotic cardiovascular diseases (ASCVD) are still the leading
cause of morbidity and mortality in 24 Bosnia and Herzegovina. Elevated LDL-cholesterol is …
cause of morbidity and mortality in 24 Bosnia and Herzegovina. Elevated LDL-cholesterol is …
Prevention of cardiovascular disease: are we successful?
G De Backer - European Heart Journal Open, 2022 - academic.oup.com
Although the age-standardized mortality rates from cardiovascular disease (CVD) have
declined significantly in most high-income countries from the seventies of the previous …
declined significantly in most high-income countries from the seventies of the previous …
[HTML][HTML] Estimación sustentable del riesgo cardiovascular con las tablas predictivas de Gaziano sin laboratorio
J Betancourt Bethencourt, G Brunet Bernal… - Revista Finlay, 2022 - scielo.sld.cu
Fundamento: identificar factores de riesgo cardiovascular es muy importante, pues al
realizar acciones para contrarrestarlos, la probabilidad de presentar enfermedades …
realizar acciones para contrarrestarlos, la probabilidad de presentar enfermedades …
Targeting cardiovascular and metabolic disorders through annual nationwide screening and lifestyle intervention: insights from a cohort of 5 819 041 subjects with a 4 …
Cardiovascular and metabolic disorders are among the leading causes of morbidity and
mortality. Therefore, interventions aimed at reducing cardiovascular risk are the mainstay of …
mortality. Therefore, interventions aimed at reducing cardiovascular risk are the mainstay of …
[PDF][PDF] Refining the classification of cardiovascular prevention
RA Guerreiro - Revista Portuguesa de Cardiologia, 2024 - Elsevier
The prevention of coronary artery disease (CAD) is a critical focus area in cardiology. As per
the 2021 European Society of Cardiology (ESC) guidelines on cardiovascular disease …
the 2021 European Society of Cardiology (ESC) guidelines on cardiovascular disease …
[PDF][PDF] Two different approaches to assess adherence to medication in Polish cohort of the EUROASPIRE V registry
A Kubica, P Michalski, M Kasprzak… - Medical Research …, 2022 - journals.viamedica.pl
Two different approaches to assess adherence to medication in Polish cohort of the EUROASPIRE
V registry Page 1 108 www.journals.viamedica.pl/medical_research_journal ORIGINAL ARTICLE …
V registry Page 1 108 www.journals.viamedica.pl/medical_research_journal ORIGINAL ARTICLE …